AlphaFold predicted structure
PGM3 · O95394

Mean pLDDT
95.5/ 100
Very high
542 residues
Confidence breakdown
- Very high(≥ 90)92%
- Confident(70–90)7%
- Low(50–70)0%
- Very low(< 50)0%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
phosphoglucomutase 3
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Congenital disorders of glycosylation
BIALLELIC, autosomal or pseudoautosomalCOVID-19 research
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalPrimary immunodeficiency or monogenic inflammatory bowel disease
BIALLELIC, autosomal or pseudoautosomalSevere multi-system atopic disease with high IgE
BIALLELIC, autosomal or pseudoautosomal+3 more panels — install the extension to see the full list inline on any page.
immunodeficiency 23
severe combined immunodeficiency
combined immunodeficiency
hyper-IgE syndrome
hereditary disease
Immunodeficiency
immunodeficiency disease
immune system disorder
Intellectual disability
allergic rhinitis
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Phosphoacetylglucosamine mutase
Catalyzes the conversion of GlcNAc-6-P into GlcNAc-1-P during the synthesis of uridine diphosphate/UDP-GlcNAc, a sugar nucleotide critical to multiple glycosylation pathways including protein N- and O-glycosylation
PGM3 · O95394

Mean pLDDT
95.5/ 100
Very high
542 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0